When did PTC Therapeutics report Q4 2024 earnings?

PTC Therapeutics (PTCT) reported Q4 2024 earnings on February 27, 2025 after market close.

What were PTC Therapeutics's Q4 2024 revenue and EPS?

PTC Therapeutics reported revenue of $213.2M and eps of $-0.24 for Q4 2024.

Did PTC Therapeutics beat estimates in Q4 2024?

Revenue missed the consensus estimate of $249.0M by $35.8M. EPS beat the consensus estimate of $-1.12 by $0.88.

Where can I find PTC Therapeutics's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001070081-25-000012) directly on SEC EDGAR. The filing index links above go to sec.gov.

PTC Therapeutics PTCT Q4 2024 Annual earnings

Reported February 27, 2025 · After market close

Revenue$213.2MMiss by $35.8M

EPS-$0.24Beat by $0.88

Revenue estimate$249.0M

EPS estimate-$1.12

Next report

Jul 30, 2026 (Today)

Revenue estimate$298.6M

EPS estimate$0.24

Financials

Q4 2024

Income statement

See full

Revenue$213.2M-30.6%

Operating income-$162.4M—

Net income-$65.9M+57.7%

EPS (diluted)-$0.85+58.7%

Balance sheet

See full

Cash & equivalents$779.7M+31.3%

Total debt$392.3M-6.2%

Total equity-$1.1B-34.1%

Total assets$1.7B-10.1%

Cash flow

See full

Operating cash flow-$30.0M+70.1%

CapEx$3.8M-32.3%

Free cash flow-$33.8M+68.1%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$3.48B+67.3%

Enterprise value$3.09B+62.4%

P/S4.3×+2.1×

Profitability

See full

Operating margin-37.5%-6.5pp

Net margin-45%-11.1pp

FCF margin-14.2%-3.2pp

Returns & leverage

See full

Current ratio2.4×+0.3×

Segments

By segment

See full

Life Science$213.2M-9.1%

Versus estimates

Revenue

Q1 2026$272.6MBeat by $55.1M Q4 2025$164.7MMiss by $114.8M Q3 2025$211.0MMiss by $70.4M Q2 2025$178.9MMiss by $12.6M Q1 2025$1.2BBeat by $803.5M

Q4 2024$213.2MMiss by $35.8M

Diluted EPS

Q1 2026-$0.03Beat by $0.42 Q4 2025-$1.67Miss by $1.46 Q3 2025$0.20Beat by $1.39 Q2 2025-$0.83Beat by $0.24 Q1 2025$10.04Beat by $11.12

Q4 2024-$0.24Beat by $0.88

Ask the moment PTC Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did PTC Therapeutics report Q4 2024 earnings?: PTC Therapeutics (PTCT) reported Q4 2024 earnings on February 27, 2025 after market close.
What were PTC Therapeutics's Q4 2024 revenue and EPS?: PTC Therapeutics reported revenue of $213.2M and eps of $-0.24 for Q4 2024.
Did PTC Therapeutics beat estimates in Q4 2024?: Revenue missed the consensus estimate of $249.0M by $35.8M. EPS beat the consensus estimate of $-1.12 by $0.88.
Where can I find PTC Therapeutics's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001070081-25-000012) directly on SEC EDGAR. The filing index links above go to sec.gov.